Long-term Subjective Benefit With a Bone Conduction Implant Sound Processor in 44 Patients With Single-Sided Deafness

2014 ◽  
Vol 35 (6) ◽  
pp. 1017-1025 ◽  
Author(s):  
Jolien Desmet ◽  
Kristien Wouters ◽  
Marc De Bodt ◽  
Paul Van de Heyning
Author(s):  
Ann-Kathrin Rauch ◽  
Thomas Wesarg ◽  
Antje Aschendorff ◽  
Iva Speck ◽  
Susan Arndt

Abstract Purpose The new active transcutaneous partially implantable osseointegrated system Cochlear™ Osia® System is indicated in case of conductive or mixed hearing loss (CHL/MHL) with a maximum average bone conduction hearing loss of 55 dB, or in single-sided deafness (SSD). The implant directly stimulates the bone via a piezoelectric transducer and is directed by an external sound processor. We conducted a monocentric retrospective longitudinal within-subject clinical study at our tertiary academic referral center. The aim was to investigate long-term data (2017–2021) on audiological outcomes and hearing-related quality of life for the Osia system. Methods Between 2017 and 2020, 22 adults (18: CHL/MHL; 3: SSD) were implanted with the Osia100 implant; seven received bilateral implants. As of 10/2020, the sound processor was upgraded to Osia 2. Results Mean Osia system use by 04/2021 was 30.9 ± 8.6 months (range 17–40 months). Unaided bone conduction thresholds were unchanged postoperatively. One patient had to be explanted because of prolonged wound infection. Aided hearing thresholds were significantly lower compared to the unaided thresholds preoperatively, along with a marked increase in speech recognition in quiet. Speech processor upgrade resulted in a stable benefit. Patients with CHL/MHL and SSD showed a similar improvement in self-rated hearing performance revealed by SSQ, APHAB, and HUI questionnaires. Conclusion The Osia system is a safe, effective and sustainable option for treatment of conductive and mixed hearing loss or single-sided deafness.


2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Georg Sprinzl ◽  
Thomas Lenarz ◽  
Rudolf Hagen ◽  
Wolf Dieter Baumgartner ◽  
Thomas Keintzel ◽  
...  

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Alexander M. Huber ◽  
Bernd Strauchmann ◽  
Marco D. Caversaccio ◽  
Wilhelm Wimmer ◽  
Thomas Linder ◽  
...  

2015 ◽  
Vol 36 (7) ◽  
pp. 1209-1215 ◽  
Author(s):  
Józef Mierzwiński ◽  
Wiesław Konopka ◽  
Maria Drela ◽  
Piotr Łaz ◽  
Malgorzata Śmiechura ◽  
...  

2011 ◽  
Vol 51 (3) ◽  
pp. 194-199 ◽  
Author(s):  
Jacob Rasmussen ◽  
Steen Østergaard Olsen ◽  
Lars Holme Nielsen

Author(s):  
Ji Hyeon Lee ◽  
Young Joon Seo

As the technology advances and bone conduction implant (BCI) use increases, implantable bone conduction hearing aids are regarded as a treatment method for single-sided deafness (SSD) and their efficacy on SSD must be discussed. Therefore, we organized the problems of SSD and types of implantable bone conduction hearing aids and explained their effectiveness in the treatment of SSD in terms of changes in 1) speech recognition in a noisy environment, 2) sound localization, 3) subjective satisfaction as assessed by questionnaire, and 4) tinnitus. Although bone conduction hearing aids do not significantly improve localization ability in SSD, they increase the ability to listen under noise, increasing subjective satisfaction. Tinnitus improvement was also reported. The active forms of BCI like MED-EL BONEBRIDGE®2 and Cochlear Osia®2 have been developed well. Based on these technological developments and effects, bone conduction hearing aids would be a good option for treatment option of SSD.


Author(s):  
Ying Chen ◽  
You-zhou Xie ◽  
Liu-Jie Ren ◽  
Na Gao ◽  
Wen-xiu Gu ◽  
...  

Abstract: Background: Baha Attract System was designed as non-skin penetrating bone conduction implant to minimize skin complication. However, there were insufficient studies on its long-time acoustic outcome and safety in microtia patients with auricle reconstruction surgeries, who have thinner retroauricular subcutaneous layer and theoretically vulnerable skin at the implant side. Objectives: To analysis the long-term hearing performance and soft tissue complications of Baha@ Attract System in microtia population. Study Design & setting: A prospective cohort study at single tertiary referral center. Patients: Twenty Mandarin-speaking patients with congenital bilateral microtia who were underwent Baha@ Attract implantation with or without auricle reconstruction surgeries simultaneously. Main Outcome Measure(s): Comparative analysis of audiological test results including hearing thresholds and speech recognition in quiet and in noise were pre- and post-operatively performed. subjective benefit as measured with the SSQ Scale. Soft tissue outcomes were monitored and documented. Results: The mean follow-up time was 36.11±3.30 months. Significant and stable improvements in hearing threshold and speech understanding in noise and quiet were demonstrated with aided condition. Subject evaluation revealed high level of patients’ satisfaction with the amplification in all the subscales. Adverse events including skin necrosis increased after one year post-operatively. Soft tissue evolution including sin thinning, erythema, epidermis atrophy, soft tissue atrophy, skin necrosis was seen or once developed in most of the participants. However, prevalence of severe soft tissue complication was not higher to non-microtia population. Conclusions: Baha@ Attract System provides favorable and stable hearing improvements for microtia patients. Combining plastic surgeries with implantation will not increase the prevalence of soft tissue complication. However, long-term soft tissue problems should be highly aware of even after one year post implantation. Key words: Baha Attract, microtia, hearing, soft tissue, skin necrosis


2021 ◽  
Vol 70 (2) ◽  
pp. 102-108
Author(s):  
Lukáš Varga ◽  
Branislava Bercíková ◽  
Zuzana Kabátová ◽  
Milan Profant

ntroduction: Bone conduction implants are currently used for rehabilitation of conductive and mixed hearing loss as well as for single sided deafness. A growing number of these implants available on the market increases requirements on detailed knowledge on their technical properties, and on their advantages and disadvantages in clinical practice. Sophono is one of the recent members in this implant group. The aim of the study is to summarize our first experiences with Sophono at our implantation center in Bratislava. Patients and methods: We present data of the first two adult patients who underwent Sophono implantation. Both suffered from bilateral conductive hearing loss of different etiology. We focused on their audiological functional outcomes, basic surgical aspects and subjective assessment by the patients. Results: In free field tone audiometry with the implant, both patients achieved improvement of hearing thresholds by 21.25 dB and 31.25 dB, respectively. In speech tests with and without noise, we also demonstrated a clear benefit of the implant, which was in a narrow relationship with the degrees of their hearing loss: speech discrimination scores in noise were 30% and 60% in patients 1 and 2, respectively. The surgical procedure in Sophono implantation is relatively simple and does not include any work on middle ear structures. Patient satisfaction with the implant does not always correspond to the measured functional outcomes. Conclusion: The Sophono implant represents a suitable option for rehabilitation of conductive and mixed hearing loss as well as single sided deafness in selected patients. The candidate selection is always based on comprehensive assessment in which the audiological results are an elementary criterion, but definitely not a single one. Keywords: Sophono – implantation – conductive hearing loss


Sign in / Sign up

Export Citation Format

Share Document